Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.
Rammensee HG, Gouttefangeas C, Heidu S, Klein R, Preuß B, Walz JS, Nelde A, Haen SP, Reth M, Yang J, Tabatabai G, Bösmüller H, Hoffmann H, Schindler M, Planz O, Wiesmüller KH, Löffler MW.
Rammensee HG, et al. Among authors: bosmuller h.
Vaccines (Basel). 2021 Apr 24;9(5):428. doi: 10.3390/vaccines9050428.
Vaccines (Basel). 2021.
PMID: 33923363
Free PMC article.